Recent Advances in Immune Cell Therapy for Glioblastoma

Glioblastoma (GBM) is the most malignant form of astrocytoma with short survival and a high recurrence rate and remains a global problem. Currently, surgery, chemotherapy, radiotherapy, and other comprehensive treatments are the main treatment modalities, but patients still have a poor prognosis mai...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Xianhui, Zheng, Yiyang, Hong, Wandong, Chen, Xixi, Li, Huiting, Huang, Baojun, Huang, Zhenyang, Tang, Hongli, Geng, Wujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609403/
https://www.ncbi.nlm.nih.gov/pubmed/33193310
http://dx.doi.org/10.3389/fimmu.2020.544563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609403/
https://www.ncbi.nlm.nih.gov/pubmed/33193310
http://dx.doi.org/10.3389/fimmu.2020.544563

Ejemplares similares